Prostatis Group’s iShares 0-1 Year Treasury Bond ETF SHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,287
Closed -$363K 178
2025
Q3
$363K Buy
3,287
+220
+7% +$24.3K 0.09% 109
2025
Q2
$339K Buy
3,067
+543
+22% +$59.9K 0.1% 112
2025
Q1
$279K Buy
+2,524
New +$278K 0.09% 127
2023
Q4
Sell
-85,331
Closed -$9.43M 139
2023
Q3
$9.43M Buy
+85,331
New +$9.41M 4.61% 6
2023
Q2
Sell
-3,731
Closed -$411K 253
2023
Q1
$411K Buy
+3,731
New +$411K 0.22% 73

Other funds holding SHV

Prostatis Group's SHV Position: Q4 2025 in Review

Prostatis Group sold out of iShares 0-1 Year Treasury Bond ETF (SHV) in Q4 2025, closing a stake of 3,287 shares — an estimated $363K sold.

Prostatis Group first reported a position in SHV in Q1 2023 and held it in 5 quarters. The position peaked at $9.43M in Q3 2023. 709 funds tracked by Wall St. Rank hold SHV as of Q4 2025.

  • Prostatis Group reported no remaining iShares 0-1 Year Treasury Bond ETF position as of Q4 2025 after selling out during the quarter.
  • Prostatis Group sold 3,287 iShares 0-1 Year Treasury Bond ETF shares in Q4 2025, an estimated $363K.
  • Prostatis Group first reported a position in iShares 0-1 Year Treasury Bond ETF in Q1 2023 and held it in 5 quarters.
  • Prostatis Group's iShares 0-1 Year Treasury Bond ETF position peaked at $9.43M in Q3 2023.
  • 709 funds tracked by Wall St. Rank held iShares 0-1 Year Treasury Bond ETF as of Q4 2025.

Based on Prostatis Group's 13F filing for Q4 2025, filed 17 Feb 2026.